指南与共识头颈技术与安全PET

泪道闪烁显像英国核医学学会指南

Lacrimal scintigraphy BNMS Guidelines.
指南 / 共识 · Nucl Med Commun · 2021-01-01

该指南旨在帮助核医学与放射性核素放射学专家推荐、执行、解读和报告泪道闪烁显像(泪道显像)结果,协助科室制定本地方案,不规定具体相机采集技术参数,描述向双眼各滴入一滴放射性示踪剂后连续成像以显示引流受损水平并可能量化受损程度,为2018年英国核医学学会网站旧版指南的更新版。

要点

  • 向双眼各滴入一滴放射性示踪剂后连续成像,可显示泪道引流受损的解剖水平。
  • 该检查可对泪道引流受损程度进行量化评估。
  • 本指南协助科室制定本地方案,具体采集技术参数需与医学物理专家共同确定。

关键影像表现/征象

  • 向每只眼滴入一滴放射性示踪剂后连续成像,显示泪道引流受损的水平。
  • 该检查可对泪道引流受损程度进行量化。

临床应用与阅片要点

  • 本指南用于协助核医学与放射性核素放射学专家推荐、执行、解读和报告泪道闪烁显像结果。
  • 本指南协助科室制定本地方案,具体采集技术参数需与本地医学物理专家共同确定。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The purpose of this guideline is to assist specialists in Nuclear Medicine and Radionuclide Radiology in recommending, performing, interpreting and reporting the results of lacrimal scintigraphy (also known as Dacroscintigraphy). This guideline will assist individual departments to formulate their own local protocols. This does not aim to be prescriptive regarding technical aspects of individual camera acquisitions, which need to be developed in conjunction with the local experts in medical physics. There are numerous radiological techniques to assess the physiology of the lacrimal system. This guideline will describe the application of a drop of radiotracer into each eye and consecutive imaging to demonstrate the level of impaired drainage, with the possibility of quantifying such impairment. This guideline is a recent and updated version of a previously published guideline on the British Nuclear Medicine Society website in 2018 [1].

来源:Nucl Med Commun,查看原文。版权归原作者所有。

引用

  1. Costa IM, Pereira LR, Jessop M, et al. Lacrimal scintigraphy BNMS Guidelines. Nucl Med Commun. 2021. PMID: 33395194. doi:10.1097/MNM.0000000000001358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。